FindTrial
Sign In

Study on the effect and mechanism of olmesartan on endothelial progenitor cells

Study on the effect and mechanism of olmesartan on endothelial progenitor cells

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017751
Enrollment
Unknown
Registered
2018-08-12
Start date
2018-08-20
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atherosclerosis

Interventions

healthy adult male volunteers:Olmesartan
Adult male patients without cardiovascular disease:Olmesartan

Sponsors

The First Affiliated Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
45 Years to 65 Years

Inclusion criteria

Inclusion criteria: Adult male patients without cardiovascular disease or healthy adult male volunteers did not have a history of cardiovascular disease-related drug therapy; the volunteers informed consent to the studies.

Exclusion criteria

Exclusion criteria: Known cardiovascular diseases, diabetes, malignant tumors, acute or chronic infections or inflammatory

Design outcomes

Primary

MeasureTime frame
the function of endothelial progenitor cells;—

Countries

China

Contacts

Public ContactYang Zhen

The First Affiliated Hospital, Sun Yat-sen University

yangzhen10710710@163.com+86 13711234169

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026